PortfoliosLab logoPortfoliosLab logo
ALL vs. INCY
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ALL vs. INCY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Allstate Corporation (ALL) and Incyte Corporation (INCY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ALL achieves a 4.37% return, which is significantly higher than INCY's 1.89% return. Over the past 10 years, ALL has outperformed INCY with an annualized return of 14.79%, while INCY has yielded a comparatively lower 2.27% annualized return.


ALL

1D
-2.71%
1M
1.41%
YTD
4.37%
6M
8.15%
1Y
5.93%
3Y*
27.04%
5Y*
12.75%
10Y*
14.79%

INCY

1D
-1.70%
1M
2.11%
YTD
1.89%
6M
4.07%
1Y
46.34%
3Y*
18.14%
5Y*
3.15%
10Y*
2.27%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ALL vs. INCY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ALL
The Allstate Corporation
4.37%10.09%40.61%6.37%18.37%9.86%-0.12%38.82%-19.52%43.64%
INCY
Incyte Corporation
1.89%43.00%10.00%-21.83%9.43%-15.61%-0.39%37.32%-32.86%-5.55%

Correlation

The correlation between ALL and INCY is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.12

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Nov 4, 1993

0.22

The correlation between ALL and INCY shifts across timeframes, from 0.08 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ALL:

$56.46B

INCY:

$20.82B

EPS

ALL:

$45.76

INCY:

$7.06

PE Ratio

ALL:

4.70

INCY:

14.26

PEG Ratio

ALL:

0.13

INCY:

0.01

PS Ratio

ALL:

0.85

INCY:

3.81

PB Ratio

ALL:

1.91

INCY:

3.70

Total Revenue (TTM)

ALL:

$67.14B

INCY:

$5.36B

Gross Profit (TTM)

ALL:

$19.06B

INCY:

$3.76B

EBITDA (TTM)

ALL:

$13.09B

INCY:

$1.80B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ALL vs. INCY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ALL
ALL Risk / Return Rank: 4949
Overall Rank
ALL Sharpe Ratio Rank: 5151
Sharpe Ratio Rank
ALL Sortino Ratio Rank: 4444
Sortino Ratio Rank
ALL Omega Ratio Rank: 4343
Omega Ratio Rank
ALL Calmar Ratio Rank: 5454
Calmar Ratio Rank
ALL Martin Ratio Rank: 5656
Martin Ratio Rank

INCY
INCY Risk / Return Rank: 7979
Overall Rank
INCY Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
INCY Sortino Ratio Rank: 7979
Sortino Ratio Rank
INCY Omega Ratio Rank: 7777
Omega Ratio Rank
INCY Calmar Ratio Rank: 8080
Calmar Ratio Rank
INCY Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ALL vs. INCY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The Allstate Corporation (ALL) and Incyte Corporation (INCY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ALLINCYDifference
Sharpe ratioReturn per unit of total volatility

-1.16

Sortino ratioReturn per unit of downside risk

-1.64

Omega ratioGain probability vs. loss probability

1.06

1.26

-0.20

Calmar ratioReturn relative to maximum drawdown

0.52

2.54

-2.02

Martin ratioReturn relative to average drawdown

1.33

5.67

-4.34

ALL vs. INCY - Sharpe Ratio Comparison

The current ALL Sharpe Ratio is 0.25, which is lower than the INCY Sharpe Ratio of 1.41. The chart below compares the historical Sharpe Ratios of ALL and INCY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ALLINCYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.25

1.41

-1.16

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.50

0.11

+0.40

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.60

0.07

+0.53

Sharpe Ratio (All Time)

Calculated using the full available price history

0.37

0.21

+0.16

Drawdowns

ALL vs. INCY - Drawdown Comparison

The maximum ALL drawdown since its inception was -77.03%, smaller than the maximum INCY drawdown of -98.54%. Use the drawdown chart below to compare losses from any high point for ALL and INCY.


Loading charts...

Drawdown Indicators


ALLINCYDifference

Max Drawdown

Largest peak-to-trough decline

-77.03%

-98.54%

+21.51%

Max Drawdown (1Y)

Largest decline over 1 year

-11.48%

-18.33%

+6.85%

Max Drawdown (3Y)

Largest decline over 3 years

-14.11%

-33.83%

+19.72%

Max Drawdown (5Y)

Largest decline over 5 years

-27.35%

-41.53%

+14.18%

Max Drawdown (10Y)

Largest decline over 10 years

-41.39%

-66.47%

+25.08%

Current Drawdown

Current decline from peak

-3.75%

-34.08%

+30.33%

Average Drawdown

Average peak-to-trough decline

-16.44%

-59.91%

+43.47%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.81%

8.19%

-3.38%

Volatility

ALL vs. INCY - Volatility Comparison

The current volatility for The Allstate Corporation (ALL) is 8.09%, while Incyte Corporation (INCY) has a volatility of 9.23%. This indicates that ALL experiences smaller price fluctuations and is considered to be less risky than INCY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ALLINCYDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.09%

9.23%

-1.14%

Volatility (6M)

Calculated over the trailing 6-month period

17.07%

23.30%

-6.23%

Volatility (1Y)

Calculated over the trailing 1-year period

23.82%

33.04%

-9.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.44%

29.41%

-3.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.94%

34.28%

-9.34%

Dividends

ALL vs. INCY - Dividend Comparison

ALL's dividend yield for the trailing twelve months is around 2.40%, while INCY has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
ALL
The Allstate Corporation
2.40%1.92%1.91%2.54%2.51%2.75%1.96%1.78%2.23%1.41%1.78%1.93%
INCY
Incyte Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

ALL vs. INCY - Financials Comparison

This section allows you to compare key financial metrics between The Allstate Corporation and Incyte Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00B10.00B15.00B20222023202420252026
16.94B
1.27B
(ALL) Total Revenue
(INCY) Total Revenue
Values in USD except per share items

ALL vs. INCY - Profitability Comparison

The chart below illustrates the profitability comparison between The Allstate Corporation and Incyte Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%20.0%40.0%60.0%80.0%100.0%2022202320242025202600
Portfolio components
ALL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, The Allstate Corporation reported a gross profit of 0.00 and revenue of 16.94B. Therefore, the gross margin over that period was 0.0%.

INCY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a gross profit of 0.00 and revenue of 1.27B. Therefore, the gross margin over that period was 0.0%.

ALL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, The Allstate Corporation reported an operating income of 0.00 and revenue of 16.94B, resulting in an operating margin of 0.0%.

INCY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported an operating income of 301.12M and revenue of 1.27B, resulting in an operating margin of 23.7%.

ALL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, The Allstate Corporation reported a net income of 2.46B and revenue of 16.94B, resulting in a net margin of 14.5%.

INCY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Incyte Corporation reported a net income of 303.33M and revenue of 1.27B, resulting in a net margin of 23.8%.


Frequently Asked Questions


ALL and INCY have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

INCY has higher volatility (9.23%) compared to ALL (8.09%). In terms of maximum drawdown, ALL dropped -77.03% vs INCY's -98.54%.

INCY currently has the higher Sharpe Ratio (1.41 vs 0.25), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ALL and INCY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer